| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis
|
Sanyal, Arun J.
|
|
2014
|
7 |
supplement-2 |
p. 800-805
|
article
|
| 2 |
Current histological classification of NAFLD: strength and limitations
|
Bedossa, Pierre
|
|
2014
|
7 |
supplement-2 |
p. 765-770
|
article
|
| 3 |
Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
|
Duseja, Ajay
|
|
2014
|
7 |
supplement-2 |
p. 755-764
|
article
|
| 4 |
Hard clinical outcomes in patients with NAFLD
|
Kumar, Ramesh
|
|
2014
|
7 |
supplement-2 |
p. 790-799
|
article
|
| 5 |
Immune and inflammatory pathways in NASH
|
Ganz, Michal
|
|
2014
|
7 |
supplement-2 |
p. 771-781
|
article
|
| 6 |
Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH
|
Montesi, Luca
|
|
2014
|
7 |
supplement-2 |
p. 814-822
|
article
|
| 7 |
Insulin resistance, steatosis and hepatitis C virus
|
Mangia, Alessandra
|
|
2014
|
7 |
supplement-2 |
p. 782-789
|
article
|
| 8 |
Lean NASH: distinctiveness and clinical implication
|
Das, Kausik
|
|
2014
|
7 |
supplement-2 |
p. 806-813
|
article
|
| 9 |
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific
|
Vongsuvanh, Roslyn
|
|
2014
|
7 |
supplement-2 |
p. 823-832
|
article
|
| 10 |
Pharmacological agents for nonalcoholic steatohepatitis
|
Guillaume, Maeva
|
|
2014
|
7 |
supplement-2 |
p. 833-841
|
article
|
Journal description